Immix Biopharma

IMMX · NASDAQ

$8.91+$0.69 (+8.39%)TodayMarket closed ·
Prev close $8.22

Who owns IMMX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 57.1% of IMMX’s shares.

  • Janus Henderson Investors14.0%
  • Hsu (Jason)7.0%
  • Saturn V Capital Management LP6.7%
  • Eventide Asset Management, LLC5.6%
  • Next 6 largest institutions23.8%
  • All other shareholders42.9%
Top institutional holders of IMMX
HolderShares% of shares
Janus Henderson Investors9.78M14.02%
Hsu (Jason)4.87M6.97%
Saturn V Capital Management LP4.66M6.67%
Eventide Asset Management, LLC3.89M5.58%
GKCC, LLC3.24M4.64%
State Street Investment Management (US)3.00M4.29%
Deep Track Capital LP2.77M3.98%
BlackRock Institutional Trust Company, N.A.2.75M3.95%
Vanguard Capital Management, LLC2.51M3.59%
Opaleye Management Inc.2.35M3.36%

Largest mutual fund holders

Top mutual fund holders of IMMX
HolderShares% of shares
Eventide Healthcare & Life Sciences Fund2.55M3.65%
State Street SPDR S&P Biotech ETF2.22M3.18%
Janus Henderson Horizon Biotechnology1.95M2.79%
Vanguard Total Stock Market Index Fund1.78M2.55%
iShares Russell 2000 ETF1.06M1.52%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of IMMX in the last 6 months.

Latest IMMX insider transactions
InsiderTypeSharesValue
Ng CareyAward12.50K—
Ng CareyAward6.25K—
Morris Gabriel SAward500.00K—
Rachman Ilya MAward500.00K—
Chudnovsky YekaterinaAward12.50K—
Chudnovsky YekaterinaAward6.25K—
Hsu JasonAward12.50K—
Hsu JasonAward6.25K—
Marquet MagdaAward12.50K—
Marquet MagdaAward6.25K—

Short interest

Settled Sep 30, 2026

Shares short
10.39M
Days to cover
5.11
% of shares outstanding
14.89%
Average daily volume
2.03M
Change since last report
+8.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.